Resultados de la búsqueda

From 17 to 20 November, GOGOA BIOENGINEERING took part in MEDICA 2025  in Düsseldorf – the world’s foremost trade fair for medical technology and healthcare innovation. With more than 5,800 exhibitors from over 70 countries  and around 80,000 visitors representing 165 nations , including a remarkably high proportion of senior decision-makers, MEDICA continues to stand as the pre-eminent global rendezvous for those shaping the future of medicine. For GOGOA BIOENGINEERING, a European leader in exoskeletons and advanced neurorehabilitation technologies, MEDICA is not merely an event: it is the arena in which the next decade of healthcare is outlined, negotiated, and built. Our presence this year revolved around three key pillars: Showcasing our work within the REVITAL European project  at the project’s dedicated stand. Delivering a company pitch at the International Cross-Border Pitching Event @ MEDICA 2025 , organised by Life Science Nord, WTSH, IB.SH , IHK zu Lübeck  and the Enterprise Europe Network (EEN) . Engaging in a highly productive schedule of meetings with hospitals, clinical groups, distributors, innovation clusters and technology providers from across the world. MEDICA: Why This Fair Truly Matters Held annually since the late 1960s, MEDICA  has evolved into the most influential showcase of global healthcare innovation. Beyond its extensive exhibition halls, MEDICA features: dedicated forums on digital health and clinical software , high-profile competitions for healthtech start-ups, the German Hospital Conference , thematic areas such as the Hospital of the Future  and the START-UP PARK . For hospital directors, clinical chiefs, policymakers, and medical technology investors, MEDICA functions as a strategic observatory  – a place to understand which technologies are clinically mature, which partnerships are emerging, and which innovations are set to define tomorrow’s healthcare delivery. REVITAL: Bringing Advanced Neurorehabilitation and Telecare to Rural Regions Throughout MEDICA, GOGOA BIOENGINEERING was represented at the stand of the European project REVITAL – Socioeconomic revitalisation of low-density population areas through clinical telecare  (S1/4.5/E0037), co-funded by Interreg VI-B Sudoe 2021–2027  through the European Regional Development Fund (ERDF) , with a total budget exceeding €2.1 million. A Strategic Challenge: Ageing, Rurality and Access to Care REVITAL tackles a common challenge in Southern Europe: ensuring equitable access to specialised care for populations living in sparsely populated, ageing territories such as: Castilla y León (Spain) Beira Baixa (Portugal) The French Basque Country Here, distances, demographic decline and limited clinical infrastructure often prevent timely access to physiotherapy, neurorehabilitation and multidisciplinary care. GOGOA BIOENGINEERING’s Contribution to REVITAL As a medtech manufacturer and neurotechnology innovator, GOGOA BIOENGINEERING contributes: its portfolio of clinical exoskeletons  – HANK (gait), BELK (knee), and HELK (injury-prevention for professionals), its operational experience from our own MOVEX CLINICS  in the Basque Country, its technological capabilities in tele-rehabilitation, VR therapy and remote patient engagement , and its expertise in integrating robotics within multidisciplinary clinical pathways. The results are already tangible: in the French Basque pilot alone, more than 40 patients have benefited  from exoskeleton-assisted therapies guided by physiotherapists, occupational therapists, speech therapists and rehabilitation physicians. A Transferable Model for Hospitals and Regional Health Systems REVITAL offers a fully transferable model with clear value for healthcare managers: Hybrid care pathways : combining on-site sessions with remote monitoring and digital rehabilitation. Objective, data-driven rehabilitation : continuous metrics on mobility, effort, adherence and progress. Local socioeconomic impact : creation of new roles, services and territorial healthcare capacities. For regions facing demographic decline and workforce shortages, REVITAL demonstrates a viable, scalable and clinically robust approach to modernising care delivery. International Cross-Border Pitching @ MEDICA 2025 Another milestone of our presence at MEDICA was our participation in the International Cross-Border Pitching Event , held on 19 November in the North German Pavilion (Hall 15 / E13) . Organised by Life Science Nord (LSN) , WTSH , IB.SH , IHK zu Lübeck , and the Enterprise Europe Network (Hamburg–Schleswig-Holstein) , this prestigious event selected companies from across Europe to present in a condensed “2–3 minute, one-slide” format, followed by an exclusive networking reception. Our pitch focused on: our suite of medical exoskeletons , our capacity to deploy turnkey neurorehabilitation units , and our role as a trusted technological partner  within European collaborative projects such as REVITAL. This opportunity arose through the active support of the Bilbao Chamber of Commerce  and our long-standing collaboration with WTSH  and the broader Enterprise Europe Network , all of whom play an essential role in helping European SMEs connect, grow, and internationalise. Enterprise Europe Network & WTSH: Strategic Allies for Innovation and Internationalisation The Enterprise Europe Network (EEN)  is the world’s largest support network for SMEs, composed of more than 600 organisations in over 60 countries , funded by the European Union. Through WTSH, companies receive: expert guidance for internationalisation, access to matchmaking platforms and partnership databases, opportunities for participation in R&D consortia, and support that is entirely free of charge , owing to EU funding. Figures such as Paula Decker , Foreign Trade Consultant at WTSH, play a pivotal role in connecting enterprises across Europe, enabling companies such as GOGOA BIOENGINEERING to engage with the innovation ecosystem of northern Germany. What We Learnt at MEDICA 2025: Five Key Trends Shaping Global Healthcare 1. Artificial Intelligence Becoming Tangible Clinical Infrastructure AI is no longer confined to prototypes: it is now embedded in diagnostic imaging, emergency triage, documentation automation and remote patient monitoring. Hospitals increasingly ask not “What can AI do?” but “How do we integrate it responsibly?” 2. Robotics and Exoskeletons Becoming Standard Medical Equipment Exoskeletons are now listed alongside treadmills, balance systems and electrotherapy devices. Their clinical acceptance is accelerating rapidly, driven by evidence, ergonomics and workforce sustainability. 3. Telemedicine and Telerehabilitation Completing the “Hospital Without Walls” Healthcare systems worldwide are shifting towards hybrid models that combine remote follow-up, digital exercise platforms and in-clinic robotics. REVITAL stands as a demonstration of this future made reality , particularly in underserved territories. 4. Workforce Shortages and Ergonomics as Top Priorities The global shortage of clinicians and the rise of musculoskeletal injuries among healthcare workers are shaping investment decisions. Exoskeletons designed for professional use (such as HELK) are now considered essential tools for workforce sustainability. 5. Europe’s Strategic Drive for Collaborative Healthcare Innovation Programmes such as Interreg , Horizon Europe  and EIT Health  are supporting high-impact, multi-country projects aimed at rethinking long-term care, rehabilitation, ageing and digital health. REVITAL fits precisely within this European vision. A Highly Successful MEDICA – and a Springboard for What Comes Next Our participation in MEDICA 2025 concluded with: an exceptionally active presence at the REVITAL stand, a high-profile pitch opening new avenues with university hospitals, clusters and distributors, and the confirmation that our strategy – robotics, neurotechnology and integrated rehabilitation services – aligns perfectly with global healthcare trends. To Our Partners, Clients and Future Collaborators If you are: a director of rehabilitation, neurology, orthopaedics  or occupational health, a hospital manager or policymaker planning to modernise care pathways, or a regional authority exploring solutions for rural or dispersed populations, we would be delighted to share the insights and solutions presented at MEDICA, and to explore how the REVITAL model and GOGOA BIOENGINEERING technologies  can be adapted to your specific context. At GOGOA BIOENGINEERING we remain committed to a simple principle: Technology fulfils its purpose only when it reaches the people who need it most – wherever they may live.

Workforce absenteeism has become one of the most significant threats to industrial competitiveness in Spain. Over the past decade, the average number of hours lost per employee has more than doubled, positioning the country among the European nations with the highest absenteeism rates. In strongly industrial regions such as the Basque Country, this challenge is even more pronounced: the prevalence of temporary incapacity and long-term sick leave consistently exceeds national averages. The consequences are substantial—lost productivity, increased operational costs, pressure on teams, and a gradual erosion of industrial performance. In this context, merely “managing” absenteeism is no longer sufficient; today, it must be prevented . 1. A Challenge Far Beyond Human Resources Absenteeism has become a strategic concern. Its effects extend directly to: Operational continuity  and production capacity Direct and indirect labour costs Workforce planning , particularly in labour-intensive environments Organisational health and team morale , strained by understaffing Long-term competitiveness  in increasingly demanding markets Not surprisingly, sectors with greater physical demands—manufacturing, automotive, metalwork, logistics, construction—record the highest levels of sick leave. 2. The Underlying Causes Behind Rising Absenteeism Although absenteeism has a multifactorial origin, two principal drivers consistently emerge: a) Musculoskeletal Disorders (MSDs) Often caused by repetitive movements, sustained postures, manual handling of loads or overhead work. MSDs lead to chronic pain, accumulated fatigue, reduced performance, and recurrent long-term leave. b) Stress and Mental Health Strain Increasing production pressure, lack of staffing flexibility, high pace of work and cumulative physical effort create conditions where stress and burnout amplify the risk of absence. In an industrial territory such as the Basque Country, these factors interact with particular force, contributing to above-average absenteeism. 3. Prevention as a Strategic Investment Advanced prevention is not an additional cost; it is an investment with direct, measurable returns. Acting before an injury occurs leads to: Reduced pain and improved worker wellbeing Fewer and shorter sick-leave episodes Greater workforce stability Lower turnover and replacement costs More consistent operational performance To be truly effective, however, prevention must be supported by technology, ergonomics, and robust data . 4. The Contribution of GOGOA BIOENGINEERING: Technology Designed to Protect People and Strengthen Industry GOGOA BIOENGINEERING develops advanced biomechanical solutions to reduce physical strain, prevent injuries, and enhance occupational health in high-demand environments. Our approach is built upon three pillars: 4.1 Industrial Exoskeletons We design and integrate passive and active exoskeletons that: Reduce muscular load in the shoulders, neck, and lumbar region Lower physical effort during repetitive or sustained tasks Improve the long-term sustainability of physically demanding work Prevent MSDs linked to overexertion and fatigue 4.2 Advanced Ergonomic Assessment Prior to any implementation, we conduct a professional, data-driven assessment of each workstation: Biomechanical requirements Postural load and fatigue Movement repetition analysis Risk indicators and micro-injury patterns This ensures that the selected solution is appropriate, effective, and designed to deliver tangible improvements. 4.3 Integration, Training, and Ongoing Support Technology achieves its full potential only when integrated correctly. For this reason, we provide: Training for users, supervisors, and H&S teams Guided adaptation during the initial deployment phase Monitoring of real-world usage Evaluation of measurable impact on occupational health This comprehensive model ensures adoption, continuity, and long-term return on investment. 5. Results: Fewer Injuries, Less Sick Leave, Greater Productivity Organisations that implement exoskeletons and advanced ergonomic strategies report: Significant reductions in musculoskeletal discomfort Fewer MSD-related absences Shorter recovery periods Improved workforce retention Sustained increases in operational efficiency In sectors where absenteeism carries a direct economic burden, these results are essential for maintaining competitiveness. 6. Conclusion: Prevention Is Not an Expense — It Is Strategy Spain faces a structural challenge in workforce absenteeism, and the Basque Country—owing to its dense industrial base—experiences this pressure intensely. However, today we have the technological tools to protect people while enhancing industrial performance. When applied with expertise and supported by rigorous assessment, technology becomes a decisive ally. At GOGOA BIOENGINEERING, we are committed to one principle: a workplace where employee health and industrial productivity advance together. If your organisation seeks to reduce absenteeism, improve ergonomic conditions, and implement physical-assistance technologies, our team stands ready to support you. #OccupationalHealth #WorkplaceSafety #IndustrialErgonomics #ExoskeletonTechnology #Absenteeism #WorkerWellbeing #WearableTechnology #Industry40 #IndustrialInnovation #GOGOABIOENGINEERING #BasqueTechnology

On 30 October, GOGOA BIOENGINEERING had the privilege of taking part in the Jornada Forestal Madera , held at the Bilbao School of Engineering (EHU) as part of the XI Basque Wood Week. This event—driven by Baskegur in collaboration with the Basque Government, Osalan and EuskadiPreben, within the PRISMA Project—served as a forum to reflect upon and propose meaningful improvements in the working conditions across the forestry and timber value chain. The conference was formally opened by Lourdes Iscar , Director of Osalan, and Iker Iglesias , Director of Food Industry and Policy at the Basque Government. Osalan went on to present its targeted Action Plan for the forestry sector, together with an in-depth analysis of accident rates within this strategically important field. One of the central segments was the session devoted to the Next Generation Project: Forestry Exoskeletons , which explored the potential of these technologies to enhance ergonomics, reduce risk, and strengthen the wellbeing of professionals working within the forestry sector. In this context, GOGOA  shared its expertise and the progress achieved within the project led by HAZI , in which our exoskeletons are being assessed as supportive tools for tasks such as felling, delimbing, and other physically demanding operations. Furthermore, we presented the advancements of the GAIA Project  (Comprehensive Management for the Prevention, Suppression, and Reforestation of Forest Fires), where sensor-equipped exoskeletons  are being integrated into the protective suits of operators involved in reforestation and fire-suppression activities, enabling continuous health monitoring and the early detection of potential risk situations. GAIA is a project subsidised by the CDTI, originating from the Ministry of Science, Innovation and Universities. The event also featured a series of round-table discussions , focusing on the key challenges identified by EuskadiPreben: fostering a genuine culture of prevention, strengthening hands-on training, promoting professional specialisation, and consolidating the role of public administrations in improving working conditions. Representatives from the forestry sector, together with officials from the provincial councils of Álava, Bizkaia and Gipuzkoa, as well as technical leads from Osalan and Baskegur, all contributed to these conversations. The conference concluded with remarks by Inés Álvarez , Deputy Technical Director of Osalan, who presented the final insights before the networking session and formal closure of the event. At GOGOA BIOENGINEERING, we reaffirm our unwavering commitment to innovation that elevates workplace safety and occupational health—driving forward technological solutions designed to empower forestry teams and contribute to a safer, more resilient and more sustainable sector.ás seguro, eficiente y sostenible.

From 24 to 26 October 2025, FisioExpo  transformed IFEMA Madrid into the leading epicentre of physiotherapy: over 10,000 m² of exhibition space, more than 170 exhibitors, upwards of 150 workshops and lectures, and thousands of professionals from across Spain and Portugal eager to witness where the profession is truly heading. As representatives of GOGOA BIOENGINEERING , we attended as professional visitors with a clear purpose: to listen attentively to physiotherapists , to observe which emerging technologies are genuinely making a difference, and to determine whether our vision of robotic neurorehabilitation  aligns with the sector’s evolving expectations. FisioExpo 2025: where physiotherapy shifts decisively into the future A single walk through the exhibition hall allowed visitors to move seamlessly from traditional physiotherapy equipment to an array of cutting-edge solutions: diathermy and shockwave systems novel approaches in diamagnetic therapy advanced gait and balance assessment platforms virtual reality and gamified  rehabilitation tools and an increasingly prominent presence of robotics and sophisticated clinical technology The takeaway was unmistakable: physiotherapy is no longer defined merely by treatment couches. The field has entered a technological, data-driven and multidisciplinary era . Three key insights we took from FisioExpo 1. Robotics is no longer a luxury – it is becoming a clinical necessity More and more practitioners now regard exoskeleton-based rehabilitation  and robotic neurorehabilitation  as essential tools for complex cases: stroke, spinal cord injury, neurodegenerative diseases, and post-operative orthopaedic recovery. In the corridors, we repeatedly heard: “With exoskeletons, I can safely multiply the number of gait repetitions .” “Patients can see  their progress in a very tangible way.” “We need technology that helps us achieve more in less time .” For us, as designers and manufacturers of medical-grade exoskeletons , this is a powerful validation: robotics has moved from being a promising concept to becoming established clinical reality . 2. The data-free era is over Another undeniable trend emerged: a strong appetite for objective data —and plenty of it. comprehensive strength and range-of-motion metrics detailed logs of repetitions, load, and fatigue digital reports that enhance clinical follow-up Physiotherapy is rapidly evolving into a metrics-based discipline , where patient progression is documented with verifiable, quantifiable information. Our exoskeletons do not merely mobilise the patient; they also capture meaningful data  that supports treatment personalisation, justifies clinical decisions, and clearly communicates progress. 3. Technology, yes—but designed for the physiotherapist’s real-world workflow Physiotherapists are not seeking additional administrative weight. They want intuitive tools  that integrate effortlessly into their daily routine. The most commonly expressed needs included: simple, elegant interfaces pre-configured clinical protocols equipment that can be used by multiple therapists  without friction close technical support  and continuous training Innovation is welcome—but only when it elevates  rather than complicates clinical practice. At GOGOA, this is precisely our design philosophy: solutions that work within real clinical sessions , lasting 45–60 minutes, in real centres, with real patient flow. Where GOGOA BIOENGINEERING fits within this new physiotherapy landscape GOGOA BIOENGINEERING  is a Basque medical technology company dedicated to the design, manufacture, and commercialisation of exoskeletons, medical devices , and robotic neurorehabilitation systems  for clinical environments. Our technologies are already in operation in: pioneering robotic neurorehabilitation centres , specialising in exoskeleton-based therapy for stroke, spinal cord injury, and neurodegenerative conditions hospital units such as Quirónsalud Bizkaia , home to the first hospital-based robotic neurorehabilitation unit in northern Spain Everything we observed at FisioExpo reinforces that we are advancing in precisely the right direction: Physiotherapy is seeking advanced yet user-friendly solutions Patients are demanding greater therapeutic intensity Centres are investing in technology that delivers demonstrable clinical value Our commitment is unequivocal: to bring clinical robotics into everyday practice , accelerating recovery and enhancing therapeutic accuracy. What comes next? We left FisioExpo 2025 with new ideas, new collaborations on the horizon, and a strong conviction: the next phase of physiotherapy can be distilled into three words: robotics, data, and collaboration. At GOGOA, we are already working towards: new collaborative initiatives  with clinics and hospitals specialised training programmes  in exoskeletons and medical devices pilot projects  for centres ready to take a decisive qualitative leap Are you a physiotherapist or a clinic director? Let’s talk Whether you attended FisioExpo 2025 or simply wish to explore new possibilities: integrating exoskeletons and medical devices  into your rehabilitation pathways learning from the real experiences of other centres assessing the feasibility of a pilot implementation We would be delighted to speak with you. The future of physiotherapy has already begun—and we would be honoured to shape it with you .

From 4 to 7 November, GOGOA  took an active part in A+A 2025 , the world’s leading international trade fair for workplace safety, occupational health and risk prevention, held in Düsseldorf (Germany). This event is widely regarded as the global benchmark for organisations and professionals committed to enhancing wellbeing and safety at work through technological innovation. In this edition, GOGOA  engaged closely within the EXOPARK , a dedicated demonstration space focused exclusively on exoskeletons and physical assistance technologies. This environment enables visitors to experience, compare and assess  how such solutions can effectively reduce muscular fatigue , prevent musculoskeletal injuries , and improve performance in physically demanding tasks . A Setting for Connection, Learning and Strategic Partnership Participation in EXOPARK enabled GOGOA  to: • Observe the most current trends in industrial exoskeletons and supportive wearable technologies. • Establish new strategic partnerships  with companies, distributors, and international research centres. • Exchange real-world implementation experiences across sectors such as automotive, manufacturing, logistics and advanced maintenance. • Promote an implementation approach grounded in data, ergonomics, and continuous on-site support . Commitment to Health and Workplace Wellbeing GOGOA  is a European reference in applied bioengineering, specialising in the design and development of exoskeletons for industrial, clinical and rehabilitation applications. Our purpose is to enhance physical capability , safeguard health , and foster working environments that are safer, more sustainable, and more efficient . We collaborate closely with companies to: • Analyse tasks and musculoskeletal risk factors • Identify the most suitable assistance solution for each use case • Train and support users and prevention teams • Measure impact and ensure stable, long-term adoption Looking Ahead Following A+A 2025, GOGOA  is entering a new phase of pilot projects, international collaborations and case-study validation . Our objective remains unchanged: to create technology that is useful, accessible, and genuinely centred on people . Interested in exploring how exoskeletons could improve ergonomics in your organisation? We are ready to help you evaluate the potential and guide the process. Contact us and let’s move forward together. Contact (+34) 666 325 361 info@gogoa.eu c / Arzubia 10B, 7 bajo 48220 Abadiño (Bizkaia) SPAIN – EUROPE

In the furrows and in the warehouses — where the working day is measured in repeated gestures and in arms that sustain the harvest — a deliberate, practical response is being trialled: ExoKOOP , a pilot project that deploys and evaluates passive exoskeletons across Basque cooperatives to mitigate musculoskeletal fatigue and enhance ergonomics without compromising productivity. This is no abstract experiment: it is an intervention in everyday toil, founded upon people, empirical evidence and practicable recommendations. Executive summary — why this matters ExoKOOP arises from a fundamental premise: to protect the health of those who labour the land . Its proposition is both lucid and measurable: introduce passive exoskeletons — devices without motors, based upon variable-deformation elastomers that emulate muscle-like behaviour  — into genuine field and logistics tasks; quantify their effect upon posture, fatigue and performance; and distil that evidence into repeatable protocols for cooperatives. It is technology in the service of work: discreet, functional and humane. What precisely is ExoKOOP? ExoKOOP is an applied pilot with a clear objective: to reduce the risks posed by repetitive movement, sustained postures and manual handling. The methodology is straightforward and rigorous: compare, in authentic working conditions, cohorts operating with and without exoskeletons; record entire shifts; and gather both objective metrics and first-hand testimony from the workforce. The aim is not rhetorical demonstration but quantification and actionable outcomes. Where and which tasks are being tested Trials take place within cooperatives that exemplify the sector’s operational variety: Field — harvesting and transport:  repeated cycles of picking, bending, lifting and moving boxes in seasonal crops (currently tomato and guindilla). Logistics — warehousing:  loading and unloading, sack handling and continuous manual throughput. The approach is realistic and whole-shift focused: we observe work in the round, not in isolated snapshots. Who participates — the institutional and operational partnership KONFEKOOP (Confederation of Cooperatives of Euskadi):  institutional coordinator and conduit to the cooperatives; prevention and operational liaison led by Sergio Achicallende . Barrenetxe S. Coop.:  field trial host for agricultural operations. Tiendas San Isidro de Mungia S. Coop.:  logistics and warehouse validation. GOGOA BIOENGINEERING:  designer and supplier of the passive exoskeletons, provider of implantation methodology and of MonitorEX , the instrumentation platform that renders subjective experience into actionable data. This alliance combines practical expertise with technical responsibility so that the intervention is at once respectful of operations and robust in its methodology. Technology: passive exoskeletons — silent, purposeful support There are no motors, no batteries — assistance is derived from intelligent materiality : Variable-deformation elastomers  that store and return energy in a controlled fashion. The devices accompany movement rather than dictate it, alleviating load without impeding natural motion. Models under evaluation: ExoSoft  (lumbar support), ExoArms  (upper-limb assistance), ExoShoulder  (support for overhead work) and ExoHead  (cervical and scapular relief). Benefits include minimal maintenance, straightforward fitting, compatibility with personal protective equipment and favourable acceptance among workers. Here, innovation is materially modest and functionally profound: simplicity serving the human body. MonitorEX: measuring to decide, not to persuade Where anecdote ends and policy begins, measurement must take the lead. MonitorEX  captures posture and fatigue markers across full shifts, enabling: Quantitative comparison between cohorts with and without devices. Correlation of objective indicators (posture, task time, breaks) with subjective reports (perceived exertion, comfort). Formulation of precise guidance: which device, which setting, and which training regime deliver benefit. The principal data collection commenced in late October, with a notable recording session on 28 October , followed by successive iterations of adjustment and worker feedback. What has been achieved so far — trials, evidence and voices Deployment of multiple passive models across participating cooperatives. Continuous recording during authentic tasks based upon a comparative experimental design. Systematic feedback from workers on perceived relief, fit and usability. Preparation of dissemination materials: newsletters, a best-practice memo and professionally produced video content. Public communication: participation in an episode of Onda Vasca  to present the project and foreground the perspectives of those in the field and the technical team.🎧 Listen here: https://www.ondavasca.com/la-innovacion-ha-entrado-en-el-campo-vasco-con-exoesqueletos-para-proteger-la-salud-de-los-trabajadores-agrarios/ Preliminary findings and a cautious interpretation We do not trade in grand claims. Early indications are encouraging — there is perceived reduction in fatigue in specific tasks and positive reception where fit and instruction are meticulous — yet scaling must await robust statistical analysis and the establishment of training protocols. ExoKOOP seeks operational conclusions, not premature headlines. Professional films and a practical memorandum To make the learning transferable, we are producing a series of professional films that will document: Field demonstrations. Testimonies from workers and technicians. Adjustment procedures and operational recommendations. These films, together with a formal best-practice memorandum, will constitute the practical handbook for those intent on replication. Next steps — a practical roadmap Conclude data collection and complete comparative analyses. Publish the best-practice memorandum with technical recommendations and training protocols. Release the professional video series and convene demonstration days across the Basque provinces. Prepare tailored replication proposals for other cooperatives and logistics centres. For cooperative managers — the proposition in brief ExoKOOP offers a replicable procedure: diagnose, implement, instrument with MonitorEX, measure and deliver a concise, practicable report with clear decisions. If you oversee operations with significant physical demands and wish to evaluate an intervention with rigour, GOGOA BIOENGINEERING, in partnership with KONFEKOOP, will design and execute the pilot so that investment in health returns operational and human dividends.

📹 Full video of the conference available at the end of this article. 21 October 2025. Hospital Quirónsalud Bizkaia, Erandio. At six o’clock in the evening, the auditorium was already full. Healthcare professionals, physiotherapists, engineers, patients and families gathered with a shared sense of hope: to witness how technology can change lives. The First Conference on Health and Robotic Neurorehabilitation, organised by Hospital Quirónsalud Bizkaia and Gogoa Mobility Robots, marked a turning point. The event commemorated the first anniversary of the Robotic Neurorehabilitation Unit at Hospital Quirónsalud Bizkaia , as well as the tenth anniversary of GOGOA  — a decade in which the Basque company has led innovation in health-focused robotics, developing solutions that are already transforming motor and cognitive rehabilitation. An alliance that unites science, technology and humanity The conference was formally opened by Carlos F. Isoird, CEO of GOGOA , who shared a clear and inspiring vision: “The rehabilitation of the future will be technological, personalised and profoundly human.” That statement perfectly encapsulates the spirit of the pioneering collaboration between GOGOA and Hospital Quirónsalud Bizkaia, which has given rise to a unique model of care. Within the Robotic Neurorehabilitation Unit, technology is placed at the service of each individual, adapting to their diagnosis, abilities and recovery goals in a hospital environment. Each treatment is designed in a personalised manner, combining the clinical expertise of the physiotherapy team with the use of advanced robotic devices developed by GOGOA: lower-limb and upper-limb exoskeletons, stimulation systems and virtual reality, among others. Humanising technology During her address, Sara García , neurological physiotherapist and head of the Unit, explained that their daily work begins with understanding each patient’s needs before introducing any technology: “The first step is to know the person — to understand where they are now and where they can go. Technology helps refine the therapy, but the key remains human.” The event also gave a voice to Alberto Yanes , a patient with cervical myelopathy, who recounted his progress since beginning treatment: “I arrived with balance problems and, after just a few sessions, I could already feel a great improvement.” His sincere and humble testimony moved the audience and gave a human face to what innovation truly means: walking again, regaining independence — in short, reclaiming life. The Exo Show: innovation in motion The most eagerly awaited moment of the evening came with the Exo Show  — a live demonstration of the technology developed by GOGOA. Attendees witnessed HANK , the lower-limb robotic exoskeleton designed for gait rehabilitation, in full operation, alongside other solutions currently used within the unit. Isoird explained that the development of these devices is based on a fundamental principle: absolute personalisation . Each system adapts to the patient, not the other way round. Therapists can adjust parameters in real time, ensuring natural and safe movement throughout the rehabilitation process. The scene perfectly encapsulated the central message of the event: technology does not replace the professional — it amplifies their ability to help. Science and shared experience The conference concluded with a round table moderated by Alejandra de Miota , featuring Carlos F. Isoird , Guillermo Asín  (GOGOA’s Director of R&D), Sara García , Dr. Alejandro Durán  (Head of the Neurology Department at Hospital Quirónsalud Bizkaia), and Alberto Yanes , a patient of the unit. Dr. Durán emphasised the essential role of robotics in the treatment of neurological conditions, both acute and chronic: “Any condition that causes neurological deficit can benefit from robotic neurorehabilitation. It is never too late to begin.” He also stressed: “Technology helps us prevent the loss or paralysis of vital functions, such as eating or walking. Rehabilitation is essential to stop patients from deteriorating or, at the very least, to slow the decline in functional mobility.” For his part, Guillermo Asín  highlighted the value of uniting engineering and medicine: “Useful robotics is not the most spectacular, but the kind that adapts and measures therapy according to the patient’s progress.” A future that is already present The First Conference on Health and Robotic Neurorehabilitation was far more than a record-breaking event. It confirmed that the partnership between GOGOA and Hospital Quirónsalud Bizkaia is setting a new standard in neurological rehabilitation — a model founded on evidence, personalisation and the union of science and humanity. In a world where neurological challenges increase every year, this alliance demonstrates that clinical robotics is now an essential tool , capable of multiplying opportunities for recovery and restoring hope to thousands of people. The event concluded with heartfelt applause and a shared certainty: innovation does not only move muscles — it moves lives. From GOGOA, we extend our deepest gratitude to all speakers, healthcare professionals, patients, families and attendees who made this historic day possible. Your dedication and enthusiasm inspire us to continue building, together with Hospital Quirónsalud Bizkaia, the future of robotic neurorehabilitation. 📹 Full video of the event GOGOA Hospital Quirónsalud Bizkaia neurorrehabilitación robótica jornada GOGOA Hospital Quirónsalud Bizkaia neurorrehabilitación robótica jornada

Published: 20 October 2025 The European project REVITAL – Socioeconomic revitalisation of sparsely populated areas through clinical telecare  has taken a decisive step forward in Portugal. On 8 October , the Escola Superior de Saúde Dr. Lopes Dias (ESALD) , part of the Instituto Politécnico de Castelo Branco (IPCB) , hosted the first clinical training and testing session with the HANK and BELK exoskeletons , developed by Gogoa Mobility Robots . This initiative demonstrates how advanced robotic rehabilitation, virtual reality and tele-rehabilitation technologies  can be deployed beyond major hospitals and brought directly to rural populations with limited access to specialised care . REVITAL: Innovation and Healthcare at the Service of the Community REVITAL  is a cross-border European initiative financed by the Interreg VI-B Sudoe 2021–2027 Programme , with a total budget of €2,131,109 , of which €1,598,331.75 is co-funded by the European Regional Development Fund (FEDER) . Its mission is to: Improve access to specialised healthcare and neurorehabilitation  in low-density regions of Spain, Portugal and France. Combat rural depopulation  by creating new health, technology and rehabilitation services. Promote social innovation and digital health , empowering local professionals and institutions. The project is coordinated by the SIVI Cluster (Innovative Solutions for Independent Living)  and includes partners such as AEBB , ESALD/IPCB , Gogoa Mobility Robots , the University of Deusto , ESTIA (France)  and various healthcare organisations across the Sudoe region. Clinical Training with HANK and BELK at ESALD During this first session, physiotherapists and lecturers from ESALD received technical and clinical training in two key robotic rehabilitation systems: HANK  – a lower-limb exoskeleton for gait rehabilitation  in individuals with stroke, spinal cord injury or neurodegenerative conditions. It enables precise, repetitive and measurable training sessions . BELK  – a motorised knee exoskeleton  designed to support knee extension, gait stability and post-injury recovery , in both unilateral and bilateral configurations. Training included: Patient set-up and calibration Safety and inclusion criteria Adjustment of assistance levels Recording of gait parameters (cadence, step length, symmetry, fatigue, perceived exertion) Data logging for clinical monitoring and future research Next Steps: Clinical Pilots in Castelo Branco and São Miguel d’Acha In the coming weeks, real patient trials will begin  in two pilot sites: ESALD’s Pedagogical Clinic (Castelo Branco) São Miguel d’Acha , a rural community participating in the REVITAL programme The clinical pilots aim to evaluate: Improvements in gait, balance and activities of daily living Acceptance of robotic rehabilitation by patients and healthcare professionals Effectiveness of hybrid care models combining in-person therapy and tele-rehabilitation Reduction in travel for rural populations requiring long-term rehabilitation Gogoa Mobility Robots: Democratizing Robotic Rehabilitation As a technological partner, Gogoa Mobility Robots  contributes: Advanced clinical exoskeletons : HANK (gait), BELK (knee) and HELK (lumbar support) Specialised training for physiotherapists and clinicians Expertise in clinical protocols, biomechanical data analysis and performance indicators Support to scale and replicate the model across other rural regions in the Sudoe area Impact of REVITAL ✔ Improved access to specialised rehabilitation  in rural areas ✔ Higher therapy intensity and measurable clinical outcomes  through robotic assistance ✔ New professional opportunities in digital health and physiotherapy 4.0 ✔ Transferable, scalable model  for other rural communities in Spain, Portugal and France Conclusion REVITAL illustrates how technology, healthcare and territorial cohesion  can work together to reduce inequalities in access to rehabilitation. Thanks to initiatives like this, robotic neurorehabilitation is no longer limited to large urban hospitals , but is reaching local communities, elderly populations and patients with mobility impairments . If your clinic, hospital or university is interested in implementing robotic rehabilitation or collaborating in European innovation projects, contact Gogoa Mobility Robots.

Chronic Pain, HSP & PLS — How GOGOA Brings Hope Today, 17 October 2025 , we mark two deeply meaningful observances: the World Day Against Pain  and the first-ever World Day of Hereditary Spastic Paraparesis (HSP)  and Primary Lateral Sclerosis (PLS) . Two distinct commemorations, yet united by a shared purpose — the pursuit of quality of life  for those living with chronic pain or neurological conditions that restrict movement. This year, patient associations around the world  — including AEPEF  in Spain — have joined forces to raise awareness, call for stronger research investment, and promote access to advanced therapeutic solutions . Understanding HSP and PLS Hereditary Spastic Paraparesis (HSP)  and Primary Lateral Sclerosis (PLS)  are rare neurodegenerative disorders  that primarily affect motor function . 🧠 HSP  (Hereditary Spastic Paraparesis) comprises a group of genetic conditions that cause progressive weakness and stiffness in the legs , often making walking and balance increasingly difficult. In more complex forms, other systems such as vision, coordination, or sensation may also be involved. 🧬 PLS  (Primary Lateral Sclerosis) is a slowly progressive upper motor neuron disease , leading to spasticity, rigidity, and gait difficulties , and in later stages, may affect speech or swallowing . Although its progression tends to be slower than that of other motor neuron diseases, its impact on everyday life can be profound  — walking, standing, or maintaining balance become daily challenges. These disorders not only affect the body — they test one’s independence, confidence, and emotional resilience , both for those who live with the disease and their loved ones. World Day Against Pain: Relief is a Human Right The World Day Against Pain , led by the IASP  and endorsed by the WHO , reminds us that relieving pain is a fundamental human right . Chronic pain affects more than 20% of the global population , and within many neurological conditions, it remains one of the most invisible and misunderstood symptoms . This day calls for breaking stigma, driving research, and ensuring that all people have access to effective and safe pain management therapies . How GOGOA Helps At GOGOA , we believe that technology must serve people .Our mission is to develop neurorehabilitation and assistive technologies  that blend science, engineering, and empathy  to enhance mobility, independence, and quality of life. Working alongside clinicians, therapists, researchers, and patients , we deliver innovative therapies that integrate neuromodulation, robotics, and personalised clinical programmes . 1️⃣ Non-invasive Neuromodulation with ALPERK ALPERK  is our non-invasive vagus nerve stimulation (VNS)  device, designed to boost neuroplasticity  — the brain’s ability to reorganise and form new connections — and to support both motor and cognitive recovery . Clinical studies have demonstrated that pairing vagus nerve stimulation with therapeutic exercise  can significantly improve motor outcomes after stroke.Our goal with ALPERK is to bring these benefits into non-invasive, safe, and accessible clinical settings . The vagus nerve also plays a crucial role in pain modulation and inflammatory response regulation , making neuromodulation an emerging ally  in managing chronic pain and spasticity . Benefits for Patients with HSP, PLS or Chronic Pain Improves muscle tone regulation  and reduces fatigue. Enhances motor therapy outcomes  when paired with functional exercise. Promotes better pain control  by influencing the autonomic nervous system. ALPERK is a non-invasive  medical technology, always applied under clinical supervision , and acts as a complementary therapy  alongside standard medical and rehabilitation treatments. 2️⃣ Robotic Therapy and Exoskeletons Robotic-assisted therapy  enables patients to relearn movement  in a safe, intensive, and motivating way.At GOGOA, we design and manufacture rehabilitation and assistive exoskeletons  that help individuals with neurological disorders walk, strengthen muscles, and maintain proper posture  — even when their nervous system can no longer fully coordinate movement. These therapies: Provide repetitive and precise practice , activating the neural circuits responsible for movement. Can help reduce spasticity  and improve coordination. Increase motivation and engagement , allowing patients to witness measurable progress. 3️⃣ Personalised Programmes: Technology That Adapts to You No two people are alike. Our programmes are custom-designed  to suit each individual’s diagnosis, abilities, environment, and goals. A treatment plan may include: Comprehensive evaluation  (gait, strength, pain, fatigue, balance). A combined plan  of ALPERK neuromodulation , robotic or conventional physical therapy , and therapeutic education  for self-care and pain management. Ongoing monitoring  and adjustment based on measurable outcomes. Who We Work With 👩‍🦽 Patients and Families: We help people regain mobility, confidence, and independence  through safe, comfortable, and motivating therapy sessions. 👩‍⚕️ Healthcare Professionals: We provide training, clinical support, and data analysis  to integrate neuromodulation and robotics into rehabilitation programmes. 🏥 Hospitals and Clinics: We implement certified protocols , ensure data traceability and safety , and offer continuous maintenance and technical support . A Gesture that Unites The symbol of the day is the “link” gesture , a chain representing the solidarity of the global HSP and PLS community.Today , we invite you to share your photo making the link gesture  on social media to show that no one stands alone .Tag @AEPEF  and join the international movement for visibility and research. At GOGOA, We Believe in Active Hope The future of neurorehabilitation depends on the collaboration between science, technology, and humanity .Every innovation we develop shares a single goal: that more people can move, live, and enjoy life — free from pain . 📩 Whether you are a patient, healthcare professional, or rehabilitation centre , contact us to learn how to integrate ALPERK  and our rehabilitation exoskeletons  into your therapeutic programme:👉 www.gogoa.eu Suggested hashtags: #WorldDayAgainstPain #HereditarySpasticParaparesis #PrimaryLateralSclerosis #ChronicPain #Neurorehabilitation #ALPERK #Exoskeletons #MedicalInnovation #GOGOA #NeurologicalHealth #TechnologyThatCares

PREVENZIONA x GOGOA AT WORKSAFE BARCELONA 2025 A few weeks ago, GOGOA, together with our partner PrevenZiona , took part in WorkSafe Barcelona 2025 , the benchmark event for prevention, protection, and occupational health . The response was outstanding: highly technical conversations and a clear focus on real-world deployment at scale. We are grateful to all those who visited us and shared their operational challenges. Our value proposition Industrial prevention exoskeletons (GOGOA / Cyber Human Systems) Ergonomic assistance for overhead work, light-to-moderate load handling and sustained postures (shoulders, neck, lumbar region). Objective: reduction of MSD risk  and fatigue  in repetitive or static tasks, without compromising productivity. Integrated PPE solutions (PrevenZiona) Selection, fit, and implementation plans grounded in risk assessment. Innovations in hand, head and respiratory protection, fall from height, and chemical protection, with sector-specific focus. Methodology & ongoing support Integration with ergonomic assessments, pre–post  protocols, performance indicators, and a roadmap for scaling  beyond pilot. Market trends observed From pilot to rollout Growing demand for clear criteria to select use-cases and to govern change across sites. Decisions grounded in data Strong interest in objective metrics (time in awkward postures, perceived exertion, usage rates, absenteeism). Prevention as competitive advantage Ergonomics programmes geared towards sustainable operations and employer branding . Our methodological approach: from assessment to outcome Job analysis: In-situ observation; task characterisation (frequency/duration), loads, working heights and critical postures. Controlled pilot (typically 4–8 weeks): Training, individual fitting, safe-use checklists, and pre–post  measurement: Ergonomics: % reduction in time with shoulder elevation >60°, sustained lumbar flexion. People: perceived exertion (Borg), reported discomfort, adoption rate. Operations: output stability and quality integrity. Scale-up and standardisation: Procedures, eligibility criteria by workstation, maintenance and hygiene, and a dashboard with quarterly reviews . Continuous improvement: Technical and ergonomic support, micro-adjustments to process, PPE compatibility and task rotation. Sectors and use-cases generating the greatest interest Automotive & Tier-1 : overhead fastening and assembly, inspection above shoulder height. Logistics : picking at lower/mid levels with repetitive flexion. Food & beverage : replenishment and sustained-rhythm operations. Maintenance & facility services : cabling, luminaires, ducting and overhead supports. Key questions and our position Do exoskeletons replace other control measures? No. Exoskeletons are a complement  within the hierarchy of controls. Engineering and organisational measures are prioritised; where these are not feasible or sufficient, exoskeletons provide effective mitigation  of exertion. How do you ensure workforce adoption? Early engagement with teams, on-shift trials, individual fitting, concise training, PPE compatibility, and follow-up. The felt benefit  is decisive for adherence. What about maintenance and hygiene? Low maintenance: routine cleaning, visual checks, replacement of wear parts, and protocols tailored to sector requirements. The GOGOA + PrevenZiona advantage Rigorous use-case selection : we deploy when it truly adds value; if not, we advise against it with clear technical criteria. Reduced learning curve : fitting, training, and on-site support to accelerate adoption. Measured impact : ergonomic, health, and operational KPIs with traceability for decision-making. Programme sustainability : operational standardisation and continuous improvement aligned with business objectives. Thank you To everyone who visited our stand, thank you  for your time and for the quality of the conversations. Your emphasis on evidence, safety and performance reflects a maturing market and raises the bar for prevention in Spain. If you were unable to attend, you may review our capabilities and request a workplace assessment: → Discover how we can help:   www.cyberhs.eu About GOGOA / Cyber Human Systems GOGOA is a leading biomedical engineering company specialising in the development and deployment of industrial and rehabilitation exoskeletons , with a focus on safety, ergonomics and sustainable productivity . Through Cyber Human Systems , we transfer cutting-edge technology to industrial environments under robust quality and regulatory standards. About PrevenZiona PrevenZiona is a specialist partner in occupational risk prevention  and PPE , providing end-to-end services from risk assessment and solution selection to implementation and follow-up. Keywords:  industrial exoskeletons, occupational risk prevention, ergonomics, MSD, occupational health, PPE, sustainable productivity, implementation, continuous improvement. Hashtags: #WorkSafeBarcelona #PPE #OccupationalSafety #RiskPrevention #Ergonomics #Industry #WorkplaceHealth #SafetyCulture #CHS #GOGOA #PrevenZiona gogoa-prevenziona-exoesqueletos-prl-worksafe-2025 gogoa-prevenziona-exoesqueletos-prl-worksafe-2025

Dubai, October 2025. At the world’s grandest stage for technology and innovation — where artificial intelligence, biotechnology, and advanced robotics converge — one European company shines with singular brilliance.  Gogoa Mobility Robots , a pioneer of Basque bioengineering, has been  officially invited to participate in GITEX Global 2025 , the most prestigious technology and innovation event on the planet. This invitation arrives in a milestone year:  Gogoa celebrates its tenth anniversary  as a company that has transcended the limits of robotics to become a  global benchmark in biomedical engineering and life-enhancing technologies for health, prevention, and human performance . GITEX GLOBAL 2025: THE STAGE WHERE THE FUTURE TAKES SHAPE From  13 to 17 October , the  Dubai World Trade Centre  and  Dubai Harbour  will host more than  200,000 visitors  and  6,000 exhibitors  from 170 nations. GITEX Global  is far more than a technology fair; it is the meeting point where the world’s foremost innovators debate, experiment, and envision the decade ahead. From artificial intelligence and biotechnology to digital health, clean energy, cybersecurity, and smart mobility, GITEX gathers under one roof the forces that are redefining the future.And this year, among global giants,  Gogoa will stand as the new frontier of bioengineering — applying science and design to advance health, prevention, and human capability. GOGOA: A DECADE LEADING THE NEW ERA OF BIOENGINEERING What began ten years ago as a Basque start-up devoted to exoskeletons for neurorehabilitation has evolved into an international company that designs, develops, and integrates  technologies aimed at expanding both physical and cognitive capacity . At Gogoa, engineering is never an end in itself, but a  means to elevate human potential . Today, its innovation ecosystem embraces three major domains: Health and Functional Recovery:  robotic solutions, cognitive systems, and intelligent therapies that optimise motor, neurological, and mental rehabilitation. Prevention and Well-being:  biomedical technologies that analyse, strengthen, and preserve muscular and neurological function, reducing risk of injury and deterioration. Sport and Performance:  tools that enable elite athletes and professionals to enhance performance, resilience, and recovery through data, neurostimulation, and advanced feedback. “At Gogoa we don’t just help people walk again — we help the world move forward. Our purpose is to unlock human potential, from the patient who learns to trust their body once more to the athlete striving to surpass their own limits.” —  Galder Arego, Brand Strategy Director, GOGOA Mobility Robots IN DUBAI: TECHNOLOGY THAT UNITES SCIENCE AND LIFE At  GITEX Global 2025 , Gogoa will present a new paradigm in bioengineering —  systems that merge artificial intelligence, adaptive robotics, biomechanical analytics, and applied neuroscience .The goal: to design intelligent therapeutic environments and sustainable experiences of human enhancement. During the event, Gogoa will unveil: Clinical and modular exoskeletons , suitable for both rehabilitation and physical training. Integrated cognitive-motor systems , capable of measuring and enhancing brain performance during movement. Advanced biomechanical assessment platforms  for injury prevention and performance optimisation. Tailored therapeutic projects , combining data, sensors, and predictive analytics to personalise every recovery journey. “The future of healthcare will not merely cure or restore — it will anticipate, enhance, and prevent. Gogoa is building that future.” —  Carlos F. Isoird, CEO, Gogoa Mobility Robots AN INVITATION THAT CELEBRATES EUROPEAN EXCELLENCE GITEX’s invitation acknowledges not only technological innovation but also the global impact of Gogoa’s distinctive model: a company that designs technology, applies clinical science, and operates its own network of therapeutic centres —  Gogoa Clinics , where research translates directly into tangible outcomes. This complete ecosystem — from design to clinical application — has positioned Gogoa as a  leader in integrated biomedical engineering , capable of bridging academia, industry, and human experience. INTERNATIONAL GROWTH AND EXPANSION Gogoa’s participation in GITEX cements its international projection. The company already develops projects and partnerships across  Europe and the United States , while its 2025–2030 strategy targets  new markets in the Middle East, Asia, and Latin America . With sustained investment in R&D —  over 30% of annual revenue dedicated to innovation  — Gogoa is shaping a future in which bioengineering becomes a driver of economic, medical, and social progress. “From the Basque Country to the world. We aim to prove that European innovation can lead the global transformation of health and human performance.” —  Guillermo Asín, R&D Director, Gogoa Mobility Robots GOGOA AT GITEX: TO LEAD IS TO INSPIRE In Dubai, Gogoa will showcase more than technology — it will share a vision:  a bioengineering that unites science, technology, and purpose. Where others display algorithms or prototypes, Gogoa will present  a new way of understanding human potential . Because leadership is not only about innovation. Leadership is about inspiration. And at  GITEX Global 2025 , Gogoa will demonstrate that  engineering can be every bit as human as the heart that drives it. GOGOA MOBILITY ROBOTS Global leader in bioengineering for health, prevention, and human performance.

Last week, the consortium of the  VIVELAB-EXO  project undertook a pivotal phase of data collection and evaluation within the  Human-Centric Laboratory  at CTAG’s state-of-the-art facilities. This milestone underscores the shared commitment of all partners to transform industrial ergonomics and exoskeleton deployment into a measurable, safe, and widely accessible reality. What is VIVELAB-EXO? VIVELAB-EXO  is an initiative co-funded by  EIT Manufacturing , uniting the expertise of  CTAG ,  ViVeTech Nyrt. ,  GOGOA Mobility Robots , and  FAREL Plastics  (a Wirthwein Group company). Its mission is to pioneer an innovative methodology to evaluate the ergonomic benefits of exoskeletons, harnessing the power of  advanced simulation  and  human digital twins . The vision is bold yet clear: to deliver a tool that accelerates the adoption of physical assistance devices across manufacturing and beyond, providing quantifiable evidence of their ability to reduce strain, prevent musculoskeletal disorders, and enhance worker well-being. Scientific and Technical Challenges The creation of human digital twins seamlessly integrated with exoskeleton models poses a fascinating array of challenges: Multimodal data capture – encompassing kinematics, muscular forces, posture, fatigue, and workload. Coupled human–machine simulation – ensuring biomechanical models truly reflect real-world behaviours. Experimental validation with participants – calibrating digital models with empirical data. Decision-making interfaces – enabling ergonomists and industry leaders to interpret simulations with clarity and confidence. Recent Progress at CTAG In this latest campaign at CTAG: Extensive human data collection was carried out under controlled conditions simulating industrial tasks. Comparative assessments were undertaken to quantify the biomechanical differences between scenarios with and without exoskeleton assistance. These data sets are now feeding into the calibration of simulation models and digital twins. The exercise reinforced the cross-sector collaboration of the consortium, a decisive element in ensuring scientific rigour and industrial relevance. Such laboratory trials are indispensable, ensuring that digital simulations remain firmly anchored in reality, whilst providing invaluable insight into improvements required for real-world applications. Why It Matters for GOGOA As a core partner,  GOGOA  brings expertise in exoskeleton technology and industrial integration. The success of VIVELAB-EXO directly enhances our mission to set the standard in physical assistance solutions. Key benefits include: Delivering a digital decision-making tool for manufacturers to anticipate the impact of exoskeletons before large-scale adoption. Lowering barriers to acceptance by providing robust, quantitative evidence of ergonomic benefits. Cementing GOGOA’s role as a European frontrunner in industrial ergonomics and human-centred robotics. Moreover, synergies with the  SUPERHUMAN project  reinforce our trajectory towards next-generation solutions for fatigue mitigation and safe human-robot collaboration. The Road Ahead The forthcoming stages of VIVELAB-EXO will include: Refinement of digital twin models, drawing upon broader datasets and diverse industrial scenarios. Validation in real-world industrial environments, beyond the laboratory. Development of intuitive dashboards and interfaces to guide ergonomic decision-making. Adaptability across contexts, ensuring applicability to varied exoskeleton types and work settings. Long-term impact assessments, examining reductions in injuries, absenteeism, and worker fatigue. Conclusion The milestone reached at CTAG is more than a research exercise; it is a decisive step towards re-imagining how industry safeguards its workforce.  VIVELAB-EXO  epitomises the convergence of technology, ergonomics, and human-centred design, with GOGOA proudly contributing to this European endeavour. We remain steadfast in our mission: to make tomorrow’s factories safer, more efficient, and fundamentally more humane. Onwards we go!  🚀 #Innovation #Technology #Exoskeletons #Ergonomics #DigitalTwins #Industry40 #Manufacturing #PhysicalAssistance #EITManufacturing #Gogoa